Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Efficace

Showing results (1-10 of 279) with videos related to

Pageof 28
Sort By:
Death Studies|October 19, 2002
Spiritual issues and quality of life assessment in cancer careFabio Efficace, Robert Marrone
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Toward a clearer understanding of the prognostic value of health-related quality-of-life parameters in breast cancerFabio Efficace, Andrew Bottomley
Expert Review of Hematology|November 10, 2018
Time for patient reported outcomes assessment in routine hematology practice: the case of chronic myeloid leukemiaFabio Efficace, Francesco Cottone
Current Medical Research and Opinion|May 5, 2016
Health-related quality of life outcomes in chronic myeloid leukemia patients treated with second generation tyrosine kinase inhibitors: do we know enough?Massimo Breccia, Fabio Efficace
The Lancet. Oncology|October 14, 2019
Quality of life and CAR-T cell therapy in children, adolescents, and young adults with haematological malignanciesFabio Efficace, Marco Vignetti
The Lancet. Oncology|January 9, 2003
Assessing HRQOL: a neglected issue for high-grade gliomaFabio Efficace, Andrew Bottomley
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Do quality-of-life randomized clinical trials support clinicians in their decision-making?Fabio Efficace, Andrew Bottomley
British Journal of Haematology|February 22, 2020
Importance of quality of life in early phase clinical trials: A case study of selinexor in multiple myelomaRajshekhar Chakraborty, Fabio Efficace
Hematology. American Society of Hematology. Education Program|December 4, 2016
The value of quality of life assessment in chronic myeloid leukemia patients receiving tyrosine kinase inhibitorsFabio Efficace, Laura Cannella
Expert Review of Anticancer Therapy|August 22, 2025
Advancing patient-centered care in myelodysplastic syndromes/neoplasms with oral therapiesPasquale Niscola, Fabio Efficace
Pageof 28

Showing results (1-10 of 279) with videos related to

Sort By:
Pageof 28
Death Studies|October 19, 2002
Spiritual issues and quality of life assessment in cancer careFabio Efficace, Robert Marrone
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Toward a clearer understanding of the prognostic value of health-related quality-of-life parameters in breast cancerFabio Efficace, Andrew Bottomley
Expert Review of Hematology|November 10, 2018
Time for patient reported outcomes assessment in routine hematology practice: the case of chronic myeloid leukemiaFabio Efficace, Francesco Cottone
Current Medical Research and Opinion|May 5, 2016
Health-related quality of life outcomes in chronic myeloid leukemia patients treated with second generation tyrosine kinase inhibitors: do we know enough?Massimo Breccia, Fabio Efficace
The Lancet. Oncology|October 14, 2019
Quality of life and CAR-T cell therapy in children, adolescents, and young adults with haematological malignanciesFabio Efficace, Marco Vignetti
The Lancet. Oncology|January 9, 2003
Assessing HRQOL: a neglected issue for high-grade gliomaFabio Efficace, Andrew Bottomley
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Do quality-of-life randomized clinical trials support clinicians in their decision-making?Fabio Efficace, Andrew Bottomley
British Journal of Haematology|February 22, 2020
Importance of quality of life in early phase clinical trials: A case study of selinexor in multiple myelomaRajshekhar Chakraborty, Fabio Efficace
Hematology. American Society of Hematology. Education Program|December 4, 2016
The value of quality of life assessment in chronic myeloid leukemia patients receiving tyrosine kinase inhibitorsFabio Efficace, Laura Cannella
Expert Review of Anticancer Therapy|August 22, 2025
Advancing patient-centered care in myelodysplastic syndromes/neoplasms with oral therapiesPasquale Niscola, Fabio Efficace
Pageof 28